Stocks
Atara Biotherapeutics (ATRA) Debt/EBITDA US GAAP (year values) |
||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | |||
| Debt/EBITDA | 0.87 | 1.64 | 1.04 | 0.80 | -0.02 | 0.25 | ||
| Changes by years, y/y, % | -34% | +90% | -36% | -23% | -103% | |||
Atara Biotherapeutics. Debt/EBITDA
Atara Biotherapeutics. Debt/EBITDA, changes, %
Atara Biotherapeutics (ATRA) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| Debt/EBITDA | 0.14 | -0.02 | -0.21 | -0.10 | 0.25 | 0.25 | ||
| Changes by years, y/y, % | -76% | -104% | -143% | -135% | +80% | |||
| Changes by quarters, q/q, % | -52% | -116% | +823% | -51% | -350% | |||
